Netspot Approval History
FDA Approved: Yes (First approved June 1, 2016)
Brand name: Netspot
Generic name: gallium Ga 68 dotatate
Dosage form: Injection
Company: Advanced Accelerator Applications USA, Inc.
Treatment for: Diagnosis and Investigation
Netspot (gallium Ga 68 dotatate) is a radioactive diagnostic agent indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors
Development History and FDA Approval Process for Netspot
|Jun 1, 2016||FDA Approves Netspot (gallium Ga 68 dotatate) Imaging Agent to Detect Rare Neuroendocrine Tumors|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.